|
|
| Alpa Laboratories Limited |
|
Financials-Alpa Laboratories Limited| Sector: Bulk Drugs and Formulations | | BSE:532878 | NSE:ALPA | Bloomberg:ALPA@IN | Reuters:ALPA.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE385I01010 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2020(3) |
31-Dec-2019(3) |
% Change |
| Sales of Products/Services |
331.64 |
241.26 |
37.46 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
11.78 |
11.64 |
1.20 |
| Total Income |
343.42 |
252.90 |
35.79 |
| Total Expenses |
-305.70 |
-222.00 |
37.70 |
| OPBDIT |
649.12 |
474.90 |
36.69 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-3.07 |
-222.00 |
-98.62 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
0.00 |
0.00 |
-- |
| After Tax Profit |
37.72 |
30.91 |
22.03 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-07(12) |
|
31-Mar-06(12) |
|
31-Mar-05(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
1013.63 |
99.94 |
705.56 |
99.85 |
373.79 |
99.79 |
| Operating Income (OI) |
1014.22 |
100.00 |
706.59 |
100.00 |
374.59 |
100.00 |
| OPBDIT |
104.99 |
10.35 |
85.44 |
12.09 |
36.90 |
9.85 |
| OPBDT |
90.89 |
8.96 |
75.97 |
10.75 |
27.79 |
7.42 |
| OPBT |
76.78 |
7.57 |
64.03 |
9.06 |
14.67 |
3.92 |
| Non-Operating Income |
0.17 |
0.02 |
0.18 |
0.03 |
0.10 |
0.03 |
| Extraordinary/Prior Period |
-0.24 |
-0.02 |
-0.53 |
-0.08 |
1.02 |
0.27 |
| Tax |
13.40 |
1.32 |
22.50 |
3.18 |
1.25 |
0.33 |
| Profit after tax(PAT) |
63.31 |
6.24 |
41.18 |
5.83 |
14.54 |
3.88 |
| Cash Profit |
77.42 |
7.63 |
53.12 |
7.52 |
27.66 |
7.38 |
| Dividend-Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| As on |
31-Mar-07 |
|
31-Mar-06 |
|
31-Mar-05 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
195.52 |
32.28 |
168.19 |
31.64 |
156.72 |
54.92 |
| Net Block |
103.90 |
17.15 |
90.63 |
17.05 |
91.06 |
31.91 |
| Capital WIP |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Investments |
0.20 |
0.03 |
0.20 |
0.04 |
0.02 |
0.01 |
| Inventory |
143.49 |
23.69 |
106.46 |
20.03 |
89.39 |
31.32 |
| Receivables |
198.07 |
32.70 |
310.39 |
58.39 |
96.89 |
33.95 |
| Other Current Assets |
160.11 |
26.43 |
23.93 |
4.50 |
8.01 |
2.81 |
| Balance Sheet Total(BT) |
605.77 |
100.00 |
531.62 |
100.00 |
285.38 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
120.60 |
19.91 |
56.39 |
10.61 |
56.39 |
19.76 |
| Reserves |
147.92 |
24.42 |
59.53 |
11.20 |
18.24 |
6.39 |
| Total Debt |
181.59 |
29.98 |
119.48 |
22.47 |
97.98 |
34.33 |
| Creditors and Acceptances |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Other current liab/prov. |
155.66 |
25.70 |
296.23 |
55.72 |
112.76 |
39.51 |
| Balance Sheet Total(BT) |
605.77 |
100.00 |
531.62 |
100.00 |
285.38 |
100.00 |
|
| As on |
31-Mar-07 |
31-Mar-06 |
31-Mar-05 |
| OPBIT/Prod.cap.empl.(%) |
20.20 |
31.25 |
13.78 |
| PBIT/Cap. Employed (%) |
20.18 |
31.08 |
14.43 |
| PAT/Networth (%) |
23.58 |
35.53 |
19.49 |
| Tax/PBT (%) |
17.47 |
35.33 |
7.91 |
| Total Debt/Networth (x) |
0.68 |
1.03 |
1.31 |
| Long Term Debt/Networth (x) |
0.00 |
0.00 |
0.00 |
| PBDIT/Finance Charges (x) |
7.44 |
8.98 |
4.17 |
| Current Ratio (x) |
3.22 |
1.49 |
1.72 |
| RM Inventory (days consumption) |
0.00 |
0.00 |
0.00 |
| FG inventory (days cost of sales) |
0.00 |
0.00 |
0.00 |
| Receivables (days gross sales) |
68.69 |
152.25 |
84.13 |
| Creditors (days cost of sales) |
0.00 |
0.00 |
0.00 |
| Op. curr. assets (days OI) |
142.00 |
226.00 |
189.00 |
|
|
Financials